These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 749196)
1. [Significance of noradrenaline in the pathogenesis of essential hypertension. Preliminary report]. Weidmann P; Keusch G; Flammer J; Ziegler WH; Reubi FC Schweiz Med Wochenschr; 1978 Dec; 108(49):1974-6. PubMed ID: 749196 [TBL] [Abstract][Full Text] [Related]
2. Increased ratio between changes in blood pressure and plasma norepinephrine in essential hypertension. Weidmann P; Keusch G; Flammer J; Ziegler WH; Reubi FC J Clin Endocrinol Metab; 1979 May; 48(5):727-31. PubMed ID: 429516 [TBL] [Abstract][Full Text] [Related]
3. Sympathetic activity and presynaptic adrenoceptor function in patients with longstanding essential hypertension. Chang PC; Kriek E; van Brummelen P J Hypertens; 1994 Feb; 12(2):179-90. PubMed ID: 8021470 [TBL] [Abstract][Full Text] [Related]
4. [Plasma adrenaline and noradrenaline in essential and renal hypertension (author's transl)]. Skrabal F; Auböck J; Hörtnagl H; von Brücke T Wien Klin Wochenschr; 1981 May; 93(10):321-5. PubMed ID: 7020260 [TBL] [Abstract][Full Text] [Related]
5. Studies on the activity of the sympathetic nervous system in essential hypertension. Chobanian AV; Garvras H; Gavras I; Bresnahan M; Sullivan P; Melby JC J Human Stress; 1978 Sep; 4(3):22-8. PubMed ID: 690418 [TBL] [Abstract][Full Text] [Related]
6. [Pathogenesis of essential hypertension. Plasma noradrenaline, plasma renin and pressor effects of noradrenaline and angiotensin in normotensive patients and patients with essential hypertension]. Philipp T Fortschr Med; 1979 Aug; 97(30-31):1315-20. PubMed ID: 468094 [TBL] [Abstract][Full Text] [Related]
7. The sympathetic nervous system in the pathogenesis of hypertension. Rahn KH; Barenbrock M; Hausberg M J Hypertens Suppl; 1999 Aug; 17(3):S11-4. PubMed ID: 10489093 [TBL] [Abstract][Full Text] [Related]
8. [Correlations between blood pressure, blood volume, plasma renin and urinary catecholamines in normal subjects and in patients with benign essential hypertension]. Weidmann P; Hirsch D; Beretta-Piccoli C; Reubi FC; Ziegler WH Schweiz Med Wochenschr; 1976 Dec; 106(49):1741-3. PubMed ID: 1013697 [TBL] [Abstract][Full Text] [Related]
9. Sympathetic activity in borderline and established hypertension in the elderly. Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB J Hypertens Suppl; 1988 Nov; 6(1):S55-8. PubMed ID: 3063795 [TBL] [Abstract][Full Text] [Related]
10. Estimation of 'total' renal, cardiac and splanchnic sympathetic nervous tone in essential hypertension from measurements of noradrenaline release. Esler MD; Jennings GL; Johns J; Burke F; Little PJ; Leonard P J Hypertens Suppl; 1984 Dec; 2(3):S123-5. PubMed ID: 6599657 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of short-term selective alpha 1-adrenergic blockade with terazosin in patients with essential hypertension. Beretta-Piccoli C; Ferrier C; Weidmann P J Hypertens Suppl; 1985 Dec; 3(3):S231-4. PubMed ID: 2908818 [TBL] [Abstract][Full Text] [Related]
13. Adrenal and sympathetic nervous activity in subjects with "low' and "high' normal blood pressure. Beilin LJ; Vandongen R; Arkwright PD; Davidson L J Hypertens; 1983 Jun; 1(1):13-8. PubMed ID: 6681025 [TBL] [Abstract][Full Text] [Related]
14. Increased plasma noradrenaline during severe sodium restriction does not stimulate platelet release in essential hypertension. Kjeldsen SE; Lande K; Gjesdal K; Jackson MB; Westheim A; Frederichsen P; Leren P; Eide I Thromb Haemost; 1986 Oct; 56(2):120-3. PubMed ID: 2949387 [TBL] [Abstract][Full Text] [Related]
15. Noradrenaline spillover and microneurography measurements in patients with primary hypertension. Jennings GL J Hypertens Suppl; 1998 Aug; 16(3):S35-8. PubMed ID: 9747908 [TBL] [Abstract][Full Text] [Related]
16. Increased urinary dopamine excretion in young patients with essential hypertension. Saito I; Itsuji S; Takeshita E; Kawabe H; Nishino M; Wainai H; Hasegawa C; Saruta T; Nagano S; Sekihara T Clin Exp Hypertens; 1994 Jan; 16(1):29-39. PubMed ID: 8136773 [TBL] [Abstract][Full Text] [Related]
17. Increased arterial catecholamine concentrations in 50-year-old men with essential hypertension. Kjeldsen SE; Eide I; Aakesson I; Leren P Scand J Clin Lab Invest; 1983 Jun; 43(4):343-9. PubMed ID: 6635541 [TBL] [Abstract][Full Text] [Related]
18. Evidence of increased peripheral catecholamine release in patients with long-standing, untreated essential hypertension. Kjeldsen SE; Flaaten B; Eide I; Helgeland A; Leren P Scand J Clin Lab Invest; 1982 May; 42(3):217-23. PubMed ID: 7134805 [TBL] [Abstract][Full Text] [Related]
19. Substance P in human essential hypertension. Faulhaber HD; Oehme P; Baumann R; Enderlein J; Rathsack R; Rostock G; Naumann E J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S172-6. PubMed ID: 2455174 [TBL] [Abstract][Full Text] [Related]
20. The acute and chronic effects of nitrendipine on plasma catecholamines in hypertensive patients. el-Beheiry H; Ruedy N; Wall RA; Murphy M; Wright JM Can J Cardiol; 1993; 9(1):41-6. PubMed ID: 8439828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]